Dätwyler (DAE) H1 2026 earnings summary

Executive summary

• Net revenue for H1 2026 reached CHF 582.7 million, up 3.5% year-over-year, with organic growth of 4.6%, driven by Healthcare and the Capsul'in acquisition despite CHF 27 million FX headwinds.

• Gross margin improved to 24.7% and EBIT margin to 13.0%, supported by favorable Healthcare mix, product mix, capacity utilization, and operational improvements.

• Healthcare division delivered 2.5% reported growth (9.5% organic), with strong demand for GLP-1, NeoFlex, and high-value solutions.

• The Forward Now transformation program is at its halfway point, delivering profitability improvements and operational efficiencies, including U.S. footprint optimization.

• Integration of Capsul'in progressed as planned, contributing to temporary increases in net debt and working capital.

Financial highlights

• EBIT grew to CHF 75.7 million (up nearly 10%), with margin improving to 13.0% from 12.2% last year.

• Net result increased to CHF 40.8 million, up 7.7% year-over-year, with net result per bearer share at CHF 2.31.

• Operating cash flow was CHF 76.7 million, with free cash flow at CHF 14.3 million, reflecting strong cash generation but higher investing activities.

• CapEx as a percentage of sales rose to 4.6%, with capital expenditures at CHF 26.8 million.

• Net debt increased to CHF 447 million post-Capsul'in acquisition, mainly due to reduced cash balances and acquisition financing.

Outlook and guidance

• Gradual increases in revenue and profitability expected, supported by strong market positions and transformation program.

• Midterm targets confirmed: higher single-digit organic revenue growth (~8% CAGR) and EBIT margin above 17%; Healthcare division EBIT margin ~22%, Industrial division EBIT margin ~12%.

• Healthcare expected to remain the main growth and earnings driver, with high-value offerings expanding and ramp-up of customer programs.

• Industrial profitability to improve in H2 as portfolio transformation and profit protection measures take effect.

• On track to achieve CHF 52 million in cumulative one-off benefits by end of 2027 and sustainable annual profitability improvement of CHF 24 million from 2028.